AI News>Press Release
- Novo Nordisk A/S: Candidate for the Board of Directors will not seek election
- “LEQEMBI®” (lecanemab) IV Maintenance Dosing for the Treatment of Early Alzheimer's Disease Approved in the United Kingdom
- Gartner Announces Pricing of $800 million of Senior Notes
- Willamette Valley Vineyards Posts Results for Q3 2025
- Ecopetrol S.A. Announces the Acquisition of a Solar Project Portfolio in Colombia
- BYND Investigation: Investors Encouraged to Contact Kirby McInerney LLP
- Cannae Holdings, Inc. Urges Shareholders to Support Its Director Nominees at December 12 Annual Meeting
- Archer's Midnight Showcases In-Country eVTOL Flight Test Campaign in UAE as Part of Its Commercial Launch Edition Program
- OFA Group Announces Rescheduled Virtual Extraordinary General Meeting of Shareholders to November 24, 2025
- Mount Logan Capital Inc. Announces Third Quarter 2025 Financial Results
- LRN Investors Have Opportunity to Lead Stride, Inc. Securities Fraud Lawsuit
- Veradace Partners Issues Presentation Detailing Why Tiptree Shareholders Should Vote "AGAINST" the Deeply Flawed Proposed Sale of Fortegra to DB Insurance
- UNDER ARMOUR EXPANDS FISCAL 2025 RESTRUCTURING PLAN AND RAISES FISCAL 2026 ADJUSTED OPERATING INCOME OUTLOOK TO $95 MILLION TO $110 MILLION
- Peregrine Energy Solutions Secures Funding to support a $317 Million Battery Energy Storage Project Currently Under Construction
- Neurogene Reports Third Quarter 2025 Financial Results and Highlights Recent Updates
- Brookfield Asset Management Announces Pricing of $600 Million Notes Due 2030 and $400 Million Notes Due 2036
- SAB BIO Reports Third Quarter Financial Results and Recent Business Highlights
- Tejon Ranch Co. CEO Issues Letter Ahead of Investor Engagement Event
- Eupraxia Pharmaceuticals Reports Additional 52-week Follow-up Data from the RESOLVE Trial in Eosinophilic Esophagitis (EoE) Demonstrating Consistent Results after Dosing with EP-104GI
- Stantec reports strong third quarter 2025 results, delivering over 17% growth in adjusted earnings per share
- Stardust Power Announces Q3 2025 Financial Results
- Graham Holdings Company Announces Pricing of $500 Million Private Offering of Senior Notes
- Contango Announces Record High $25 Million in Income from Operations and Cash Position of $107 Million for the Quarter Ended September 30, 2025
- GoPro Announces Investment from Founder and CEO Nicholas Woodman
- GDIT Expands Collaboration with Google Public Sector to Drive Mission AI Solutions
- Precision Optics Reports First Quarter Fiscal Year 2026 Financial Results
- Galantas Gold Announces Acquisition of RDL Mining Corp. with Option to Develop Indiana Gold-Copper Project in Chile and Brokered Private Placement to Raise up to $7 million
- POET Technologies Reports Third Quarter 2025 Financial Results
- Blueport Acquisition Ltd Announces Closing of $57.5 Million Initial Public Offering, Including Full Exercise of Underwriters' Over-Allotment Option
- Battalion Oil Corporation Announces Third Quarter 2025 Financial and Operating Results
- Armlogi Holding Corp. Announces Revenue Growth of 16.5% to $49.5 Million
- Electra Files Third Quarter 2025 Financial Reports
- Super League Reports Third Quarter 2025 Financial Results
- Senti Bio Reports Third Quarter 2025 Financial Results and Confirms Next Clinical Data Readout for Phase 1 SENTI-202 Study in Acute Myeloid Leukemia (AML) at the American Society of Hematology Annual Meeting in December
- Nyxoah Secures Financing Commitments of up to U.S. $77 Million to Drive U.S. Commercialization of Genio
- Vistagen Reports Fiscal Year 2026 Second Quarter Financial Results and Provides Corporate Update
- Xenia Hotels & Resorts Declares Dividend for Fourth Quarter 2025
- METALLA REPORTS FINANCIAL RESULTS FOR THE THIRD QUARTER OF 2025 AND PROVIDES ASSET UPDATES
- TELA Bio Announces Pricing of $13.0 Million Underwritten Registered Direct Offering of Common Stock and Pre-Funded Warrants
- Equillium Reports Third Quarter 2025 Financial Results and Provides Operational Update
- Reviva Reports Third Quarter 2025 Financial Results and Recent Business Highlights
- ORIC® Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Clinical and Operational Updates
- EZCORP Reports Fourth Quarter and Full Year Fiscal 2025 Results
- Alumis Reports Third Quarter 2025 Financial Results and Highlights Recent Progress
- Equifax Assists Regulated Businesses with AML Compliance
- Catheter Precision (VTAK) Reports Third Quarter and First Nine Months 2025 Results of Operations
- NANOBIOTIX Announces Curadigm Nanoprimer Platform Advancements With Updated Plans for Internal Pipeline Development and External Collaborations
- Innventure Reports Third Quarter 2025 Results
- Calidi Biotherapeutics Reports Third Quarter 2025 Financial Results and Recent Operational Highlights
- Inno Holdings Inc. Announces $50 Million “At-the-Market” Equity Offering Program